Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation

American Journal of Gastroenterology

Volumn 92, Issue 6, 1997, Pages 1005-1011

  Nakao, Kazuyuki ^a   Imoto, Ichiro ^b   Ikemura, Norihisa ^b   Shibata, Tomoyuki ^b   Takaji, Satoshi ^b   Taguchi, Yukiko ^b   Misaki, Moriharu ^b   Yamauchi, Koji ^b   Yamazaki, Natsuko ^b  

^a MIE UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; LACTOFERRIN;

ADULT; ARTICLE; BACTERIAL COLONIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; STOMACH MUCOSA; TISSUE LEVEL; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AMMONIA; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BIOLOGICAL MARKERS; BIOPSY; CHRONIC DISEASE; CLARITHROMYCIN; DUODENAL ULCER; FEMALE; FOLLOW-UP STUDIES; GASTRIC JUICE; GASTRIC MUCOSA; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-8; LACTOFERRIN; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; PYLORIC ANTRUM;

EID: 0030959170     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in chronic gastritis. Lancet 1983;i:1273-5.
2. Covacci A, Censini S, Bungnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Nat Acad Sci USA 1993;90:5791-5.
3. Wyle FA, Chang KJ. Do strains of Helicobacter pylori differ from one another? Eur J Gastroenterol Hepatol 1993;5:9-15.
4. Cover TL, Tummuru MKR, Cao P, et al. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 1994;269:10566-73.
5. Murakami M, Saita H, Teramura S, et al. Gastric ammonia has a potent ulcerogenic action on the stomach. Gastroenterology 1993;105:1710-5.
6. Azuma T, Konishi J, Tanaka Y, et al. Contribution of HLA-DQA gene to hosts response against Helicobacter pylori. Lancet 1994;343:542-3.
7. Chiba M, Ishii N, Ishioka T, et al. Topographic study of Helicobacter pylori and HLA-DR antigen expression on gastric epithelium. J Gastroenterol Hepatol 1995;30:149-55.
8. Boren T, Falk P, Roth KA, et al. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993;262:1892-5.
9. Dickey W, Collins JSA, Watson RGP, et al. Secretor status and Helicobacter pylori infection are independent risk factors for gastroduodenal disease. Gut 1993;34:351-3.
10. Crabtree JE, Shallcross TM, Heatley RV, et al. Mucosal tumour necrosis factor α and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991;32:1473-7.
11. Crabtree JE, Wyatt JI, Trejdosiewcz LK, et al. Interleukin-8 expression in Helicobacter pylori infected, normal and neoplastic gastroduodenal mucosa. J Clin Pathol 1994;47:161-6.
12. Ellison RT, Giehl TJ, Laforce FM. Damage of the outer membrane of Enteric gram-negative bacteria by lactoferrin and transferrin. Infect Immun 1988;56:2774-81.
13. Yamauchi K, Tomita M, Giehl TJ, et al. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 1993;61:719-28.
14. Ward PP, Piddington CS, Cunningham GA, et al. A system for production of commercial quantities of human lactoferrin, a broad spectrum natural antibiotic. Biotechnology 1995;13:498-503.
15. Husson MO, Legrand D, Spik G, et al. Iron acquisition by Helicobacter pylori: Importance of human lactoferrin. Infect Immun 1993;61:2694-7.
16. Dial EJ, Serna JH, Lichtenberger LM. Lactoferrin inhibits the growth of Helicobacter pylori in vitro. Gastroenterology 1995;108:A82 (abstract).
17. Dial EJ, Hall LR, Lichtenberger LM. Antimicrobial properties of lactoferrin which limit Helicobacter pylori (HP) growth. Gastroenterology 1996;110:A95 (abstract).
18. Miehlke S, Osato MS, Reddy R, et al. Direct antibacterial activity of recombinant human lactoferrin against Helicobacter pylori. Gastroenterology 1996;110:A196 (abstract).
19. Rauws EAJ, Langenberg W, Houthoff HJ, et al. Campylobacter pyloridis-associated chronic active antral gastritis; A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988;94:33-40.
20. Goossens H, Glupczynski Y, Burette A, et al. Evaluation of a commercially available complement fixation test for diagnosis of Helicobacter pylori infection and for follow-up after antimicrobial therapy. J Clin Microbiol 1992;30:3230-3.
21. Price AB. The Sydney system: Histological division. J Gastroenterol Hepatol 1991;6:209-22.
22. Tsuchihashi K, Imoto I, Shibata T, et al. Usefulness of measuring intragastric ammonia levels as a screening method for the diagnosis of Helicobacter pylori infection. Gastroenterol Endosc 1993;35:253-60 (abstract).
23. Bezwoda WR, Baynes RD, Khan Q, et al. Enzyme linked immunosorbent assay for lactoferrin plasma and tissue measurements. Clin Chim Acta 1985;151:61-9.
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
25. Kita M, Ohmoto Y, Hirai Y, et al. Induction of cytokines in human peripheral blood mononuclear cells by mycoplasmas. Microbiol Immunol 1992;36:507-16.
26. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;ii:1437-42.
27. Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990;335:1233-5.
28. Hentschel E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328: 308-12.
29. Hazall SL, Lee A, Brady L, et al. Campylobacter pyloridis and gastritis: Association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis 1986;153:658-63.
30. Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992; 102:720-7.
31. Figura N, Guglielmetti P, Rossolini A, et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989; 27:225-6.
32. Cover TL, Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992;267:10570-5.
33. Crabtree JE, Covacci A, Farmery SM, et al. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol 1995;48:41-5.
34. Gionchetti P, Vaira D, Campieri M, et al. Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori positive dyspeptic patients. Am J Gastroenterol 1994;89:883-7.
35. Carveth HJ, Bohnsack JF, Mcintyre TM, et al. Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and subendothelial matrix proteins. Biochem Biophys Res Commun 1989;162:387-93.
36. Crabtree JE. Immune and inflammatory responses to Helicobacter pylori infection. Scand J Gastroenterol 1996;215(suppl):3-10.
37. Xiang Z, Censini S, Bayeli PF, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided in two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995;63:94-8.
38. Crabtree JE, Xiang Z, Lindley IJ, et al. Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori. J Clin Pathol 1995;48:967-9.
39. Marshall BJ. Virulence and pathogenicity of Helicobacter pylori. J Gastroenterol Hepatol 1992;6:121-4.
40. Lonnerdal B, Iyer S. Lactoferrin: Molecular structure and biological function. Annu Rev Nutr 1995;15:93-110.
41. Levay PF, Viljoen M. Lactoferrin: A general review. Haematologica 1995;80:252-67.
42. Danjo Y, Lee M, Horimoto K, et al. Ocular surface damage and tear lactoferrin in dry eye syndrome. Acta Ophthalmol 1994;72:433-7.
43. Luqmani YA, Campbell TA, Bennett C, et al. Expression of lactoferrin in human stomach. Int J Cancer 1991;49:684-7.
44. Breton-Gorius J, Mason DY, Buriot D, et al. Lactoferrin deficiency as a consequence of a lack of specific granules in neutrophils from a patients with recurrent infections. Am J Pathol 1980;99:413-9.
45. Arnold RR, Brewer M, Gauthier JJ. Bactericidal activity of human lactoferrin: Sensitivity of a variety of microorganisms. Infect Immun 1980;28:893-8.